Group 1 - The Hong Kong Stock Exchange (HKEX) experienced a significant day with five companies, including Lens Technology and Geek+ Technology, listing simultaneously, marking a vibrant IPO atmosphere [1][3] - The total net proceeds from the global offerings of these five companies reached HKD 98.21 billion, with Lens Technology raising the most at HKD 46.94 billion and Dazhong Oral raising the least at HKD 1.78 billion [3] - As of July 9, 2025, stock price performances showed increases for most companies, with Lens Technology up 9.13%, Geek+ Technology up 16.02%, and Dazhong Oral up 3.50% [3] Group 2 - The IPO market in Hong Kong is witnessing a resurgence, with 44 new listings in the first half of 2025, a 47% increase from the same period last year, and total fundraising amounting to HKD 107.1 billion, a 699% increase year-on-year [5][6] - Notable IPOs include CATL, which raised HKD 35.3 billion, making it the largest IPO globally this year [5] - The trend is expected to continue, with 211 companies currently in the application process, primarily in software services, healthcare, and industrial manufacturing sectors [6] Group 3 - Deloitte China forecasts around 80 new IPOs in Hong Kong for the entire year of 2025, with expected fundraising between HKD 130 billion to HKD 150 billion, focusing on large A-share companies and leading enterprises from various regions [6][8] - The recent IPO boom is attributed to supportive policies initiated since April 2024, aimed at enhancing cross-border capital market connectivity and facilitating overseas financing for companies [8][9] - Regulatory changes have simplified the listing process, allowing companies to expedite their applications and approvals, thus attracting more firms to consider Hong Kong as a viable listing destination [9][10]

蓝思科技为全球领先的智能终端精密制造解决方案提供商，尤其在消费电子、智能汽车及新兴科技领域拥有较强的技术实力和市场地位。在此次招股中，蓝 思科技获得资金簇拥，香港公开发售获得462.76倍的认购，全球发售净筹约46.94亿港元。 港交所的锣不够敲了！7月9日，港股IPO市场迎来狂欢日，5家新贵集体敲钟。 当日在港交所挂牌上市的企业多达5家，现场热闹非凡。这5家企业分别为：蓝思科技(06613.HK)、极智嘉-W(02590.HK)、大众口腔(02651.HK)、 FORTIOR(01304.HK)以及讯众通信(02597.HK)。 | 代码 | 名称 | 米幅。 | 现价 | 上市日期� | | --- | --- | --- | --- | --- | | 1 06613 | 蓝思科技 | +3.41% | 18.800 | 20250709 | | 2 02651 | 大众口腔 | +15.75% | 23.150 | 20250709 | | 3 02597 | 讯众通信 | -0.37% | 13.500 | 20250709 | | 4 02590 | 极智嘉-W | -0.71% | 16.680 ...

Key Points - The article highlights significant stock movements in the Hong Kong and US markets, with various companies experiencing notable gains and losses due to recent developments and announcements [1][2][3][4][5] Hong Kong Market Highlights - China Rare Earth Holdings (03788) surged nearly 20%, with a year-to-date increase of 320%, as the company proposed a spin-off of its gold segment for independent listing on the Hong Kong Stock Exchange [1] - Innovent Biologics (09969) rose nearly 4% after announcing the clinical approval of its new ADC innovative drug ICP-B794 [1] - North Sea Kangcheng - B (01228) increased over 50%, with its stock price doubling in three days, marking it as a rare disease stock in the Hong Kong market [1] - Hong Kong Travel (00308) saw a rise of over 24%, achieving a year-to-date stock price doubling, driven by market speculation on stablecoin cross-border payment scenarios [1] - CSPC Pharmaceutical Group (01093) gained nearly 3% after receiving drug registration approval for Mesalazine enteric-coated tablets, enhancing its product line in the immune system treatment sector [1] - Ruian Real Estate (00272) rose over 4%, with a cumulative contract property sales amount for the first six months increasing by 457% year-on-year [1] - Cornerstone Pharmaceuticals - B (02616) increased over 3%, planning to raise HKD 467 million for clinical research on CS2009 [1] - Q Technology (01478) rose over 7%, with mobile camera module sales of 32.648 million units in June, a year-on-year increase of 1.5% [1] - Dekang Agriculture and Animal Husbandry (02419) increased by 6%, with a new cycle logic continuing to strengthen, and Tianfeng Securities set a target price of HKD 154 [1] - Contemporary Amperex Technology (03750) rose over 3%, reaching a new high since its listing, following a deepened strategic cooperation agreement with Geely Automobile [2] - Gaming stocks continued to rise, with Wynn Macau (01128) up 6.49%, New World Development (00200) up 6.15%, and others showing similar gains [2] - Gold stocks faced declines, with Golden Resources (GORO.US) dropping nearly 10% and others following suit [4] US Market Highlights - Stablecoin concept stocks continued to rise, with Tiger Brokers (TIGR.US) increasing over 8% [4] - Trump Media & Technology Group (DJT.US) rose over 2% as the company seeks SEC approval for a blue-chip cryptocurrency ETF [4] - Wolfspeed (WOLF.US) continued to rise, with stock prices increasing over 9% [4] - Intel (INTC.US) rose over 7% after announcing company-wide layoffs [4] - JD.com (JD.US) increased over 2% as it launched its "Double Hundred Plan" for its delivery service [4]

7月8日，恒基地产（HK00012，股价28.35港元）公告宣布，其间接全资附属公司Happy Ever Holdings Limited（发行人）建议进行港元有担保 可换股债券的国际发售。该债券将仅向专业投资者发售，且不会配售给恒基地产的任何关联人士。恒基地产计划将建议发行债券的所得款项 净额用于一般公司用途或再融资。 点评：此举反映恒基地产积极利用资本市场工具，灵活调整财务策略，以应对市场变化。专业投资者对此类债券的接受度，将考验公司在资 本市场的信用状况和融资能力。同时，公司需关注市场波动对债券发行的影响，确保融资计划的顺利实施。 NO.1 5家公司同日在港交所挂牌上市 7月9日，蓝思科技（HK06613）、极智嘉-W（HK02590）、峰岹科技（HK01304）、大众口腔（HK02651）、讯众通信（HK02597）共5家公 司同日在港交所挂牌上市。在7月8日的富途暗盘中，5家公司中有4家上涨。 点评：近期港股市场热度攀升，多只新股上市，反映出市场对新兴行业和科技企业的关注。这种热度背后，既体现了市场对创新和增长的期 待，也意味着投资者需关注市场波动和风险。 NO.2 恒基地产拟发行港元有担保可换股债 ...

Summary of Key Points Core Viewpoint - The Hong Kong Stock Exchange (HKEX) saw 11 companies submit applications for listing from June 30 to July 6, with no companies passing the listing hearing during this period. Additionally, 7 companies initiated their public offerings, and 5 new stocks were listed. Group 1: Companies Submitting Applications - Puxiang Health Holdings Limited is a leading provider of integrated medical and elderly care services in North China, ranking second in revenue among its peers and first in revenue growth from 2022 to 2024 [2] - Magnesium Health Technology Co., Ltd. focuses on innovative payment solutions for medical expenses, being the largest provider of innovative health insurance solutions in China by policy count [3] - Yangtuo Technology Inc. operates a trading and service platform for home care and nutrition products, holding a 10.1% market share in the low-tier market [4] - Xiamen Ruiwei Information Technology Co., Ltd. specializes in image intelligent analysis products and solutions, leveraging machine learning and computer vision technologies [5] - Zijin Gold International Limited is a leading global gold mining company, ranking ninth in gold reserves and eleventh in production as of 2024 [6] - EVE Energy Co., Ltd. is a leading lithium battery platform company, ranking first in China for consumer cylindrical battery shipments and second globally for energy storage battery shipments [7] - Zhejiang Yifei Intelligent Technology Co., Ltd. is a leading industrial robotics company in China, focusing on the light industry [8] - ChipMight Semiconductor Technology (Hangzhou) Co., Ltd. is a leading power semiconductor company, ranking second in the global OLED display PMIC market [9] - Beijing Tongrentang Medical Investment Co., Ltd. is the largest non-public Chinese medicine hospital group by outpatient and inpatient visits [11] - Shandong Linglong Tire Co., Ltd. is the largest OE tire manufacturer in China and the third largest globally [12] - Magnesium Holdings Limited is an innovative automotive technology company focused on AI-driven integrated domain control solutions [13] Group 2: Public Offerings and New Listings - Seven companies initiated their public offerings, including Anjii Foods, which had a subscription rate of 44.2 times for its public offering [14][15] - Other companies like Lens Technology and Fortior also initiated their public offerings with significant interest from cornerstone investors [16][19] - Five new stocks were listed, including Yunzhisheng, which saw a closing price increase of 44.59% on its first day [20][21][22][23] Group 3: Market Insights - The Hong Kong Stock Exchange raised over HKD 107 billion in the first half of 2025, with a 20% increase in the Hang Seng Index [24] - The biopharmaceutical sector has seen a resurgence, with 10 companies successfully listing in the first half of 2025, compared to only 12 for the entire previous year [25][26] - The total fundraising amount for the biopharmaceutical sector reached HKD 15.6 billion in the first half of 2025, indicating strong market interest [26][27]

Core Viewpoint - The Hong Kong stock market is experiencing a surge in IPO activity, with multiple companies set to list in the coming days, indicating a robust market environment for new listings [1][3][18]. Group 1: Upcoming IPOs - On June 30, six companies announced their IPOs, with plans to list between June 30 and July 4, 2025 [1][3]. - The companies planning to list include Lens Technology, Fortior, Xunzhong Communication, Jizhi Jia, Dazhong Oral, and Shougang Longze, with Lens Technology and Fortior being A-share listed companies [1][3]. - Three companies, including Taide Pharmaceutical, Yunzhisheng, and IFBH, successfully listed on June 30, 2025, with Taide Pharmaceutical's share price set at 30.6 HKD [1][4]. Group 2: Financial Performance of Listed Companies - Yunzhisheng reported revenues of approximately 601 million RMB, 727 million RMB, and 939 million RMB for 2022, 2023, and 2024, respectively, with net losses of 375 million RMB, 376 million RMB, and 454 million RMB [4][6]. - Taide Pharmaceutical raised approximately 514 million HKD, with a net amount of about 429 million HKD after expenses, and secured two cornerstone investors contributing a total of 10 million USD [8]. - IFBH raised around 1.158 billion HKD, with a net amount of approximately 1.074 billion HKD, and is recognized as the second-largest coconut water beverage company globally [8]. Group 3: Market Trends and Future Outlook - The Hong Kong stock exchange has seen over 40 new listings in the first half of 2025, a significant increase compared to the same period in 2024, with total fundraising exceeding 100 billion HKD [17]. - The market is expected to remain active, with more companies preparing for IPOs, including those that have already submitted applications [17][18]. - The trend indicates a growing interest from A-share listed companies to enter the Hong Kong market, with over 70 companies submitting applications in June 2025 alone [17].

Core Viewpoint - FORTIOR (峰绍科技) is set to launch an IPO on the Hong Kong Stock Exchange, aiming to raise approximately HKD 19.64 billion through the issuance of 16.2995 million H-shares at a price of HKD 120.5 per share [1][3]. Group 1: IPO Details - The company has entered into cornerstone investment agreements with 10 investors, collectively subscribing to approximately USD 112 million worth of shares [3]. - The expected net proceeds from the IPO are around HKD 18.46 billion [1]. Group 2: Financial Performance - FORTIOR's revenue for 2022, 2023, and 2024 is projected to be approximately RMB 3.23 billion, RMB 4.11 billion, and RMB 6.00 billion, respectively [7]. - The gross profit for the same years is expected to be around RMB 1.85 billion, RMB 2.17 billion, and RMB 3.16 billion, with net profits of RMB 1.42 billion, RMB 1.75 billion, and RMB 2.22 billion [7]. Group 3: Use of Proceeds - Approximately 34% of the net proceeds from the IPO will be allocated to enhancing research and innovation capabilities [8]. - About 10% is planned for enriching the product portfolio and expanding downstream applications [8]. - Approximately 16% will be used to expand the overseas sales network and promote products in international markets [8]. - Around 30% is expected to be allocated for strategic investments and/or acquisitions [8]. - An additional 10% is anticipated for working capital and general corporate purposes [9].